We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-10.24%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$903M
AUM Growth
-$116M
Cap. Flow
-$11.6M
Cap. Flow %
-1.29%
Top 10 Hldgs %
46.73%
Holding
67
New
11
Increased
23
Reduced
18
Closed
12

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$29.6M
2
BIIB icon
Biogen
BIIB
+$25.1M
3
COLL icon
Collegium Pharmaceutical
COLL
+$23.2M
4
AET
Aetna Inc
AET
+$21.8M
5
NUVA
NuVasive, Inc.
NUVA
+$20.5M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$45M
2
GILD icon
Gilead Sciences
GILD
+$41.5M
3
ALGN icon
Align Technology
ALGN
+$22.7M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.9M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$19M

Sector Composition

Rank Sector Weight
1 Healthcare 90.27%
2 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
51
Sarepta Therapeutics
SRPT
$1.68B
$790K 0.09%
+28,799
New +$1.16M
ALNY icon
52
Alnylam Pharmaceuticals
ALNY
$37.2B
$745K 0.08%
19,899
-5,901
-23% -$247K
TRIL
53
DELISTED
Trillium Therapeutics Inc.
TRIL
$565K 0.06%
+100,000
New +$996K
ALGN icon
54
Align Technology
ALGN
$12B
– –
-242,641
Closed -$22.7M
GILD icon
55
Gilead Sciences
GILD
$162B
– –
-524,165
Closed -$41.5M
MDT icon
56
Medtronic
MDT
$108B
– –
-521,241
Closed -$45M
NTLA icon
57
Intellia Therapeutics
NTLA
$1.49B
– –
-123,159
Closed -$2.32M
RGNX icon
58
Regenxbio
RGNX
$622M
– –
-243,613
Closed -$3.22M
TEVA icon
59
Teva Pharmaceuticals
TEVA
$36.2B
– –
-454,172
Closed -$20.9M
VRTX icon
60
Vertex Pharmaceuticals
VRTX
$122B
– –
-217,874
Closed -$19M
ISEE
61
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-389,363
Closed -$18M
LCI
62
DELISTED
Lannett Company, Inc.
LCI
– –
-21,923
Closed -$2.33M
SRRA
63
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-5,042
Closed -$399K
TMH
64
DELISTED
Team Health Holdings Inc
TMH
– –
-185,560
Closed -$6.04M
AMSG
65
DELISTED
Amsurg Corp
AMSG
– –
-96,560
Closed -$6.47M
1 2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Sectoral Asset Management held 67 positions worth $903M, down 11% from $1.02B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sectoral Asset Management's Q4 2016 filing shows 11 new, 23 increased, 18 reduced and 12 closed positions. Its largest new stake was Biogen: 84,841 shares worth $24.1M. The largest sale was Medtronic, an estimated $45M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 94% a quarter earlier, followed by Financials.

  • Sectoral Asset Management's largest Q4 2016 buy was Biogen: 84,841 shares worth $24.1M.
  • Sectoral Asset Management added most to Acadia Pharmaceuticals in Q4 2016, an estimated $29.6M increase.
  • Sectoral Asset Management's biggest Q4 2016 reduction was Incyte, cutting an estimated $18.5M.
  • Sectoral Asset Management fully exited Medtronic in Q4 2016, selling an estimated $45M.
  • Sectoral Asset Management's ten largest holdings make up 47% of its $903M portfolio in Q4 2016.
  • Sectoral Asset Management opened 11 new positions and closed 12 in Q4 2016.
  • Sectoral Asset Management's portfolio value fell 11% quarter-over-quarter to $903M.

Based on Sectoral Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.